$45M iRhythm Securities Settlement, Check If You Qualify — Glazing Employers and Glaziers’ Union Local #27 Pension and Retirement Fund v. iRhythm Technologies, Inc., No. 3:24-cv-00706-JSC

There’s about $1.83 per share waiting for you — if you bought iRhythm Technologies stock between July 25, 2022, and August 9, 2024. iRhythm agreed to pay $45 million to settle claims it misled investors about its Zio AT heart monitor. You have until October 1, 2026, to file a claim.

iRhythm Securities Settlement — Key Facts

Detail	Info
Settlement Amount	$45,000,000
Claim Deadline	October 1, 2026
Who Qualifies	All persons and entities who purchased or acquired iRhythm common stock (NASDAQ: IRTC) between July 25, 2022, and August 9, 2024
Estimated Payout	Approximately $1.83 per eligible share before court-approved fees, expenses, and costs are deducted
Proof Required (Yes/No)	Yes — brokerage trade confirmations or account statements documenting your IRTC purchases and sales
Settlement Status	Preliminarily approved July 13, 2026; final approval hearing set for November 5, 2026
Court & Case Number	U.S. District Court, Northern District of California — No. 3:24-cv-00706-JSC
Law Alleged	Securities Exchange Act of 1934, Section 10(b) and SEC Rule 10b-5; Section 20(a)
Administrator	Strategic Claims Services
Official Claim Site	irhythmsecuritieslitigation.com
Last Updated	August 4, 2026

Who Is iRhythm and Why Are They Being Sued Over the Zio AT?

iRhythm Technologies is a San Francisco digital healthcare company that makes the Zio XT and Zio AT wearable heart monitors, sold to doctors as tools to catch arrhythmias other devices miss. This lawsuit centers on the Zio AT specifically — a device iRhythm allegedly marketed as a near-real-time monitor appropriate for high-risk patients, even as internal and regulatory scrutiny raised doubts about that framing. Because Zio AT commanded premium pricing tied to those exact claims, plaintiffs argue any exaggeration went straight into iRhythm’s stock price.

What Did iRhythm Do to Investors Between 2022 and 2024?

Between July 2022 and August 2024, iRhythm and CEO Quentin Blackford allegedly told investors the Zio AT’s data transmission speed, its fit for high-risk patients, and the accuracy of what it reported were all stronger than they actually were. Plaintiffs claim those statements violated Section 10(b) of the Securities Exchange Act and SEC Rule 10b-5.

The cracks showed up in stages. A November 2022 Customer Advisory Notice — tied to an FDA inspection of the Zio AT — knocked the stock down. A May 2023 DOJ subpoena and a subsequent FDA warning letter did more damage. By the time the DOJ escalated its document fight with iRhythm in July 2024, the market had spent nearly two years re-pricing what the Zio AT actually was. The court let the core claims about the device’s timeliness, accuracy, and appropriateness for high-risk patients move forward past a motion to dismiss in June 2025, and both sides spent the next year in discovery — over 405,000 pages of documents and seven depositions — before mediation produced this settlement in April 2026.

This isn’t the first time a growth story built around one flagship product has cracked under investor scrutiny. If the per-share math in Catalent’s securities settlement sounds familiar, that’s because the recognized-loss formula here works almost the same way.

Who Qualifies for the iRhythm Securities Settlement?

Here’s exactly how to know if this case includes you.

• Anyone who purchased or otherwise acquired iRhythm common stock (NASDAQ: IRTC) between July 25, 2022, and August 9, 2024
• Investors who held shares through part of that window and sold before it ended
• Investors who still held their shares as of August 9, 2024
• Custodians and accounts that bought IRTC stock on someone else’s behalf during that window

Not everyone qualifies. iRhythm’s officers and directors during the Class Period, the immediate families of CEO Quentin Blackford and the other former named executives, and entities they control are excluded. If your only iRhythm exposure came through an employee retirement plan, don’t include those shares on your Claim Form — only shares bought outside the plan count.

You’ll need your own trade records for this one. Unlike a company-side settlement, the administrator has no record of your personal iRhythm trades — you have to provide them.

Related article: $11M Hartford & Talcott Premium Tax Settlement, Check If You Qualify — Arbuckle Funding LLC v. Talcott Resolution Life & Annuity Insurance Co., No. 7:23-cv-07972-CS

iRhythm Investors Outside California — Are You Still Covered?

Yes. This is a federal securities class action, so it covers every eligible investor nationwide regardless of where you live — California is simply where the case was filed and where iRhythm is headquartered.

Not sure if you qualify for the iRhythm securities settlement? A free consultation with a securities fraud attorney can help before the October 1, 2026 deadline.

How Much Can iRhythm Securities Settlement Class Members Get? Up to $45 Million Total

Lead Plaintiff’s damages consultant estimates the average recovery at about $1.83 per eligible share — before deducting court-approved attorneys’ fees, expenses, taxes, and administration costs. That’s only an estimate. What you actually get depends on when you bought, when you sold (or whether you still hold the stock), and how many valid claims come in.

The math behind your “Recognized Loss Amount” isn’t a flat per-share number. It’s based on how much artificial inflation the damages expert calculated was baked into the stock price on your purchase date versus your sale date — inflation that ran as high as $78.83 per share in mid-2022 and dropped to zero by August 12, 2024. If you sold after the class period closed, or still hold your shares, your loss is capped using a 90-day average closing price of $70.38.

The lawyers get paid first here too. Class Counsel can seek up to 25% of the fund — $11.25 million — plus up to $800,000 in litigation expenses. If the court approves the maximum, the estimated average cost works out to about $0.49 per eligible share, which would trim that $1.83 estimate down to roughly $1.34 per share before other deductions.

One more detail worth knowing: if your calculated payment comes out under $10, you won’t get a check. That amount gets folded into everyone else’s distribution instead.

Payments won’t go out until after the November 5, 2026 hearing, and only once any appeals are resolved. If you’re weighing whether $1.83 a share is worth the paperwork, remember that’s the high-end estimate — your actual number depends on your real trade dates.

How to File Your iRhythm Securities Settlement Claim — Step by Step

1. Go to irhythmsecuritieslitigation.com and file online, or download the Proof of Claim and Release Form
2. Gather your trade confirmations or brokerage statements showing every IRTC purchase, acquisition, and sale between July 25, 2022, and August 9, 2024
3. Enter your transaction dates, share counts, and prices exactly as they appear on your statements
4. Attach your supporting documentation — the administrator has no record of your trades without it
5. Submit online, or mail your signed Claim Form to Strategic Claims Services, P.O. Box 230, 600 N. Jackson Street, Suite 205, Media, PA 19063
6. Save your confirmation and keep copies of everything you submitted

The deadline is October 1, 2026 — still about two months out, but this is the one settlement here where finding old trade statements can genuinely take longer than filling out the form. Start pulling records now.

Should iRhythm Class Members Opt Out or Object Before October 1, 2026?

What Opting Out of the iRhythm Settlement Actually Means

Opting out means no payment from this settlement, but you keep the right to sue iRhythm and Blackford separately over the same alleged misstatements. Most people shouldn’t opt out without talking to a lawyer first — you’d be trading a guaranteed payout for an uncertain one, and iRhythm can actually terminate the entire settlement if enough investors opt out at once. The deadline is October 1, 2026, and exclusion letters must be mailed, not emailed.

How to Object to the iRhythm Settlement

Objecting keeps you in the class and eligible for a payment while letting you tell the court what you don’t like about the deal, the Plan of Allocation, or the $11.25 million fee request. Objections must be filed with the Clerk of Court at the Phillip Burton Federal Building, 450 Golden Gate Avenue, San Francisco, CA 94102, and served on Class Counsel and iRhythm’s counsel, by October 1, 2026.

Talk to a class action lawsuit attorney before October 1, 2026, if you’re weighing either option.

iRhythm Securities Settlement — Key Dates, 2026

Milestone	Date
Class period begins	July 25, 2022
Class period ends	August 9, 2024
Court preliminarily approves settlement	July 13, 2026
Lead Counsel’s fee motion filed	August 20, 2026
Claim Filing Deadline	October 1, 2026
Opt-Out Deadline	October 1, 2026
Objection Deadline	October 1, 2026
Final Approval Hearing	November 5, 2026
Expected Payment Date	UNVERIFIED — not yet announced; follows final approval and any appeals

iRhythm Securities Settlement — Frequently Asked Questions, No. 3:24-cv-00706-JSC

Do I need a lawyer to file an iRhythm securities settlement claim?

 No. The Claim Form is designed for investors to complete themselves using their own brokerage records. A lawyer matters more if you’re weighing an opt-out or have a large, complicated trading history.

Is the iRhythm $45 million settlement legitimate?

 Yes. It comes from a real case, Glazing Employers and Glaziers’ Union Local #27 Pension and Retirement Fund v. iRhythm Technologies, Inc., No. 3:24-cv-00706-JSC, pending before Judge Jacqueline Scott Corley in the Northern District of California, with Strategic Claims Services as the court-appointed administrator.

When will iRhythm settlement payments be sent?

 Not before the November 5, 2026 final approval hearing, and only after any appeals are resolved. No exact payment date has been published yet.

What if I missed the iRhythm claim deadline?

 Late claims aren’t guaranteed. Contact Strategic Claims Services at 1-866-457-5539 as soon as possible — the Court has reserved the right to allow or disallow claims on equitable grounds, but there’s no promise here.

Will my iRhythm settlement payment go on a 1099? 

Possibly — this is a securities loss recovery, so tax treatment depends on your specific trades and cost basis. Keep your Claim Form records and ask a tax professional.

How is my iRhythm settlement payout actually calculated?

 Your Recognized Loss Amount is based on the artificial inflation in IRTC’s stock price on your purchase date versus your sale date (or a capped value if you still hold the shares), then paid out pro rata from the Net Settlement Fund.

What if I only bought iRhythm call options, not the stock itself?

 Option contracts aren’t eligible securities in this settlement. If you exercised an option, the stock’s purchase date is your option’s exercise date and the purchase price is the exercise price.

What happens if I had a net gain on my iRhythm trades during the class period?

 If your overall trading resulted in a Market Gain rather than a Market Loss, your Recognized Claim is zero. You’d still be bound by the settlement, but you wouldn’t receive a payment.

Sources Used in This iRhythm Securities Article

• Court-Authorized Notice of Pendency of Class Action and Proposed Settlement: https://irhythmsecuritieslitigation.com/wp-content/uploads/sites/25/2026/07/Notice-of-I-Pendency-of-Class-Action-and-Proposed-Settlement-II-Settlement-Hearing-and-III-Motion-for-Attorneys-Fees-and-Litigation-Expenses.pdf
• Official Settlement Site — iRhythm Securities Litigation: https://irhythmsecuritieslitigation.com/
• iRhythm Holdings, Inc. Form 10-Q, SEC EDGAR filing: https://www.sec.gov/Archives/edgar/data/0001388658/000138865826000039/irtc-20260331.htm

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the court-authorized settlement notice and iRhythm Holdings’ SEC filings on August 4, 2026. Last Updated: August 4, 2026.

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.